Literature DB >> 1289368

Cerebral blood flow and cerebral oxygen consumption in patients with COPD on mechanical ventilation.

A Sari1, S Oshiata, T Toriumi, S Yamashita, S Kojima, S Kakumoto, A Yonei.   

Abstract

OBJECTIVE: To investigate the effect of PaCO2 on cerebral blood flow (CBF) in chronic obstructive pulmonary disease (COPD).
DESIGN: Before-after trial.
SETTING: General ICU in a regional hospital. PATIENTS: 7 patients undergoing mechanical ventilation because of an exacerbation of COPD. INTERVENTION: CBF and cerebral metabolic rate of oxygen (CMRO2) of COPD were measured before and after hyperventilation and were compared by those of normal patients. CBF was measured by the Kety-Schmidt technique using 15% N2O. MEASUREMENTS/
RESULTS: Hyperventilation produced a significant reduction in CBF in COPD with no concomitant change in CMRO2. CMRO2 in COPD was significantly lower than those in normal patients. The regression equation was shifted significantly more to the right in COPD.
CONCLUSION: The sensitivity of CBF in CO2 remained but CMRO2 was reduced markedly in COPD patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289368     DOI: 10.1007/bf01708580

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

1.  Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia.

Authors:  N A LASSEN; I FEINBERG; M H LANE
Journal:  J Clin Invest       Date:  1960-03       Impact factor: 14.808

2.  THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES.

Authors:  S S Kety; C F Schmidt
Journal:  J Clin Invest       Date:  1948-07       Impact factor: 14.808

3.  Real-time ultrasonic guidance for percutaneous puncture of the internal jugular vein.

Authors:  A Yonei; T Nonoue; A Sari
Journal:  Anesthesiology       Date:  1986-06       Impact factor: 7.892

4.  Cerebral blood flow and blood viscosity in patients with polycythaemia secondary to hypoxic lung disease.

Authors:  J P Wade; T C Pearson; R W Russell; G Wetherley-Mein
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-12

5.  Optimal hematocrit and blood viscosity in secondary polycythemia as determined from cerebral blood flow.

Authors:  D Menon; E L York; R A Bornstein; R L Jones; B J Sproule
Journal:  Clin Invest Med       Date:  1981       Impact factor: 0.825

6.  The effects of ketamine on cerebral circulation and metabolism in man.

Authors:  H Takeshita; Y Okuda; A Sari
Journal:  Anesthesiology       Date:  1972-01       Impact factor: 7.892

7.  Effects of Althesin on cerebral blood flow and oxygen consumption in man.

Authors:  A Sari; T Maekawa; M Tohjo; Y Okuda; H Takeshita
Journal:  Br J Anaesth       Date:  1976-06       Impact factor: 9.166

8.  Effects of psychotropic drugs on canine cerebral metabolism and circulation related to EEG--diazepam, clomipramine, and chlorpromazine.

Authors:  A Sari; Y Fukuda; T Sakabe; T Maekawa; T Ishikawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-09       Impact factor: 10.154

9.  CO2 responses of the cerebral circulation during drug-induced hypotension in the cat.

Authors:  P Gregory; T Ishikawa; D G McDowall
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

10.  Effects of venesection on cerebral function in chronic lung disease.

Authors:  R Bornstein; D Menon; E York; B Sproule; C Zak
Journal:  Can J Neurol Sci       Date:  1980-11       Impact factor: 2.104

View more
  2 in total

1.  Evaluation of psychological and physiological predictors of fatigue in patients with COPD.

Authors:  Agnieszka Lewko; Penelope L Bidgood; Rachel Garrod
Journal:  BMC Pulm Med       Date:  2009-10-21       Impact factor: 3.317

Review 2.  Medullary serotonin neurons and central CO2 chemoreception.

Authors:  Andrea E Corcoran; Matthew R Hodges; Yuanming Wu; Wengang Wang; Christie J Wylie; Evan S Deneris; George B Richerson
Journal:  Respir Physiol Neurobiol       Date:  2009-04-24       Impact factor: 1.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.